Outlook Therapeutics, Inc. - Se
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HILZINGER KURT J director
 Common Stock 79,535 $1.44 $114,530
Purchase
HILZINGER KURT J director
 Common Stock 95,597 $1.49 $142,440
Purchase
TRENARY C RUSSELL III director, officer: CEO and Pres..
 Common Stock 25,000 $1.39 $34,750
Purchase
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 25,201 $1.38 $34,777
Purchase
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 10,000 $1.42 $14,200
Purchase
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 35,200 $1.34 $47,168
Purchase
TRENARY C RUSSELL III director, officer: CEO and Pres..
 Common Stock 10,000 $1.4 $14,000
Purchase
SUKHTIAN FAISAL GHIATH director
 Common Stock 18,000 $1.4 $25,200
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 10,000 $1.39 $13,900
Purchase
SUKHTIAN GHIATH M. director, 10 percent owner
 Common Stock 16,000,000 $1.25 $20,000,000
Purchase
KENYON LAWRENCE A director, officer: CEO, Pres, C..
 Common Stock 10,000 N/A N/A
Purchase
SUKHTIAN FAISAL GHIATH director
 Common Stock 10,000 N/A N/A
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 10,000 N/A N/A
Sale
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 15,900 N/A N/A
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 8,554 N/A N/A
Sale
DAGNON TERRY officer: Chief Operating Officer
 Common Stock 63,700 N/A N/A
Sale
EVANSON JEFF officer: Chief Commercial Officer
 Common Stock 56,973 N/A N/A
Purchase
SYNTONE VENTURES LLC 10 percent owner
 Common Stock 3,000,000 N/A N/A
Purchase
SUKHTIAN GHIATH M. director, 10 percent owner
 Common Stock 8,360,000 N/A N/A
Purchase
HADDADIN YEZAN MUNTHER director
 Common Stock 10,000 N/A N/A
Purchase
SUKHTIAN FAISAL GHIATH director
 Common Stock 10,000 N/A N/A
Purchase
THURMAN RANDY H director
 Common Stock 10,000 N/A N/A
Purchase
SYNTONE VENTURES LLC 10 percent owner
 Common Stock 823,045 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Common Stock 29,358,621 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Series A-1 Convertible Preferred Stock 68,112 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Warrant (Right to Buy) 2,093,750 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Common Stock 4,657,852 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Warrant (Right to Buy) 3,636,364 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Common Stock 2,909,091 N/A N/A
Sale
KENYON LAWRENCE A director, officer: CEO, Pres, C..
 Common Stock 2,700 N/A N/A
Sale
KENYON LAWRENCE A director, officer: CEO, Pres, C..
 Common Stock 2,700 $1.7 $4,590
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Warrant (Right to Buy) 3,636,364 N/A N/A
Option
BIOLEXIS PTE LTD. director, 10 percent owner
 Common Stock 2,181,818 N/A N/A
Purchase
KENYON LAWRENCE A director, officer: CEO, Pres, C..
 Common Stock 25,000 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 5,983 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 8,200 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 6,300 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 4,890 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 5,400 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 15,884 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 10,828 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 2,266 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 10,749 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 2,300 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 800 N/A N/A
Purchase
MOHAN PANKAJ director, 10 percent owner
 Common Stock 8,000 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 2,266 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 4,399 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 6,053 N/A N/A
Purchase
HILZINGER KURT J director
 Common Stock 2,792 N/A N/A

Showing 1 to 50 of 88 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.